Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Purinergic contribution to amyotrophic lateral sclerosis
Cinzia Volonté, Savina Apolloni, Chiara Parisi, et al.
Neuropharmacology (2015) Vol. 104, pp. 180-193
Closed Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis
Cristina Ruiz‐Ruiz, Francesco Calzaferri, Antonio G. Garcı́a
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 35
Role of P2X4/NLRP3 Pathway-Mediated Neuroinflammation in Perioperative Neurocognitive Disorders
Hui Yuan, Bo Lu, Yiqin Ji, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 19
P2 receptor interaction and signalling cascades in neuroprotection
Ma Teresa Miras‐Portugal, Ma José Queipo, Juan Carlos Gil‐Redondo, et al.
Brain Research Bulletin (2018) Vol. 151, pp. 74-83
Open Access | Times Cited: 33
Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives
Marcin Cieślak, Katarzyna Roszek, Magdalena Wujak
Purinergic Signalling (2018) Vol. 15, Iss. 1, pp. 1-15
Open Access | Times Cited: 32
P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis
Paola Fabbrizio, Savina Apolloni, Andrea Bianchi, et al.
Brain Pathology (2019) Vol. 30, Iss. 2, pp. 272-282
Open Access | Times Cited: 32
Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders
Lumei Huang, Lilla Otrokocsi, Beáta Sperlágh
Brain Research Bulletin (2019) Vol. 151, pp. 55-64
Closed Access | Times Cited: 30
The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice
Diane Ly, Anjila Dongol, Peter Cuthbertson, et al.
Purinergic Signalling (2020) Vol. 16, Iss. 1, pp. 109-122
Open Access | Times Cited: 28
Purinergic signaling in oligodendrocyte development and function
Taylor G. Welsh, Sarah Kucenas
Journal of Neurochemistry (2018) Vol. 145, Iss. 1, pp. 6-18
Open Access | Times Cited: 28
Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors
Ana M. Sebastião, Nádia Rei, Joaquim A. Ribeiro
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 27
Induction of NTPDase1/CD39 by Reactive Microglia and Macrophages Is Associated With the Functional State During EAE
Marija Jakovljevic, Irena Lavrnja, Iva Božić, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 25
Functional microglia neurotransmitters in amyotrophic lateral sclerosis
Cinzia Volonté, Susanna Amadio, Paola Fabbrizio, et al.
Seminars in Cell and Developmental Biology (2019) Vol. 94, pp. 121-128
Closed Access | Times Cited: 24
Role of Cardiac A2A Receptors Under Normal and Pathophysiological Conditions
Peter Boknı́k, John Eskandar, Britt Hofmann, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 18
Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice
Éléonore Bertin, Audrey Martínez, Anne Fayoux, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 13
Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model
Savina Apolloni, Paola Fabbrizio, Susanna Amadio, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10649-10649
Open Access | Times Cited: 17
Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis
Lucas Matheus Gonçalves de Oliveira, Rodrigo Barreto Carreira, Juciele Valeria Ribeiro de Oliveira, et al.
Neurotoxicity Research (2023) Vol. 41, Iss. 3, pp. 288-309
Closed Access | Times Cited: 6
Integrative analysis of metabolomics and proteomics unravels purine metabolism dysregulation in the SOD1G93A mouse model of amyotrophic lateral sclerosis
Xiaojiao Xu, Qiu Yang, Zheyi Liu, et al.
Neurobiology of Disease (2023) Vol. 181, pp. 106110-106110
Open Access | Times Cited: 6
Molecular Structure and Regulation of P2X Receptors With a Special Emphasis on the Role of P2X2in the Auditory System
Rahul Mittal, Brandon Chan, M’hamed Grati, et al.
Journal of Cellular Physiology (2015) Vol. 231, Iss. 8, pp. 1656-1670
Closed Access | Times Cited: 20
Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders
Robert Lütjens, Jean‐Philippe Rocher
Current Opinion in Pharmacology (2017) Vol. 32, pp. 91-95
Closed Access | Times Cited: 19
A purinergic P2Y6 receptor agonist prodrug modulates airway inflammation, remodeling, and hyperreactivity in a mouse model of asthma
Anne Chetty, Azeem Sharda, Rod R. Warburton, et al.
Journal of Asthma and Allergy (2018) Vol. Volume 11, pp. 159-171
Open Access | Times Cited: 17
P2X7 receptor antagonism in amyotrophic lateral sclerosis
Ronald Sluyter, Rachael Bartlett, Diane Ly, et al.
Neural Regeneration Research (2017) Vol. 12, Iss. 5, pp. 749-749
Open Access | Times Cited: 16
Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis
Cinzia Volonté, Susanna Amadio, Francesco Liguori, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 14
Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis
Cinzia Volonté, Susanna Amadio
Neuropharmacology (2022) Vol. 221, pp. 109278-109278
Closed Access | Times Cited: 8
Mitochondrial DAMPs: Key Mediators in Neuroinflammation and Neurodegenerative Disease Pathogenesis
Haihan Yu, Kaidi Ren, Yage Jin, et al.
Neuropharmacology (2024) Vol. 264, pp. 110217-110217
Closed Access | Times Cited: 1
Ca2+ dysregulation in the pathogenesis of amyotrophic lateral sclerosis
Valentina Tedeschi, Tiziana Petrozziello, Agnese Secondo
International review of cell and molecular biology (2021), pp. 21-47
Closed Access | Times Cited: 10
Purines in neurodegeneration and neuroregeneration
Péter Illés, Alexei Verkhratsky, Geoffrey Burnstock, et al.
Neuropharmacology (2016) Vol. 104, pp. 1-3
Closed Access | Times Cited: 8

Scroll to top